title: For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA. matthew.sherwood@duke.edu
authors.forename: Matthew
authors.initials: M
authors.lastname: Sherwood
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini